Medication errors: experience of the United States Pharmacopeia (USP) MEDMARX reporting system

Area of Science:

• Health Care Quality
• Patient Safety
• Medication Error Analysis

Background:

• Medication errors represent a significant challenge within the U.S. healthcare system.
• Systematic data collection is crucial for understanding and mitigating these errors.
• The MEDMARX program provides a platform for anonymous reporting and analysis of medication errors.

Purpose of the Study:

• To analyze medication error reports submitted to MEDMARX from 1999 to 2001.
• To identify common error categories, types, causes, contributing factors, and involved products.
• To inform quality assurance, clinical practice, and health policy.

Main Methods:

• Analysis of 154,816 medication error reports from the MEDMARX database.
• Categorization of errors using the National Coordinating Council for Medication Error Reporting and Prevention's Error Category Index.
• Examination of error types, causes, contributing factors, and product involvement.

Main Results:

• Errors of omission and improper dose/quantity were the most frequently reported categories.
• Performance deficits and failure to follow protocols were consistent causes of errors.
• Distractions and increased workload were commonly cited contributing factors.
• Approximately two-thirds of reported errors reached patients, with a low incidence of harm, including 19 deaths.

Conclusions:

• Findings highlight the prevalence of specific medication error types and their root causes.
• The study provides valuable data for improving medication safety protocols and healthcare quality.
• Results have implications for enhancing clinical practices and informing health policy decisions regarding medication safety.